title: [Perineal pyoderma gangrenosum in a girl treated with adalimumab after infliximab failure].
authors.forename: Luisa
authors.initials: L
authors.lastname: Castro Laria
authors.forename: Federico
authors.initials: F
authors.lastname: Argüelles Arias
authors.forename: Manuel
authors.initials: M
authors.lastname: García Martín
authors.forename: Susana
authors.initials: S
authors.lastname: Jiménez Contreras
authors.forename: Federico
authors.initials: F
authors.lastname: Argüelles Martín
authors.forename: Juan Manuel
authors.initials: JM
authors.lastname: Herrerías Gutiérrez
mesh_terms: D000068879:Adalimumab; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D010502:Perineum; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D012074:Remission Induction; D017211:Treatment Failure
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab